Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Acute Myeloid Leukemia Clinical Trials
Acute Myeloid Leukemia clinical trials are recruiting across 134 cities. Here are the cities with the most active studies:
Acute Myeloid Leukemia Trial Phases
61 research organizations are sponsoring acute myeloid leukemia trials.
About Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a fast-growing cancer of the blood and bone marrow characterized by abnormal myeloid cells. It is the most common acute leukemia in adults. Treatment typically includes intensive chemotherapy and may involve stem cell transplant.
Clinical trials are advancing new treatments for acute myeloid leukemia. Currently, 100 studies are recruiting a combined 27,881 participants across the United States. Research is being conducted by 61 organizations including Beat AML, LLC, Massachusetts General Hospital, Wake Forest University Health Sciences and 58 others.
2026 Acute Myeloid Leukemia Research Landscape
As of July 2026, the acute myeloid leukemia clinical trial landscape includes 100 actively recruiting studies across 134 cities in the United States. These studies are collectively seeking 27,881 participants, with an average enrollment target of 279 per study.
The research spans multiple phases of development: 51 studies are in PHASE2, 45 studies are in PHASE1, 12 studies are in PHASE3, 4 studies are in NA. The presence of Phase 3 trials indicates that some acute myeloid leukemia treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 61 different organizations, including Beat AML, LLC, Massachusetts General Hospital, Wake Forest University Health Sciences, Kura Oncology, Inc., Children's Oncology Group, and 56 others. The large number of sponsors reflects significant research interest and investment in acute myeloid leukemia treatment advancement.
Geographically, acute myeloid leukemia trials are most concentrated in Houston, Texas (32 trials); Atlanta, Georgia (20 trials); New York, New York (19 trials); Los Angeles, California (18 trials); Duarte, California (17 trials) and 7 other cities.
Featured Acute Myeloid Leukemia Studies
Highlighted recruiting studies for acute myeloid leukemia, selected by enrollment size and research scope.
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
This screening and multi-sub-study Phase 1b/2 trial will establish a method for genomic screening followed by assigning and accruing simultaneously to a multi-study "Master Protocol (BAML-16-001-M1)." The specific subtype of acute myeloid leukemia will determine which sub-study, within this protocol, a participant will be assigned to evaluate investigational therapies or combinations with the ulti...
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
This research study is evaluating whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of life, symptoms, mood, coping, and end of life outcomes in patients with acute myeloid leukemia (AML).
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.
Frequently Asked Questions About Acute Myeloid Leukemia Clinical Trials
Are there acute myeloid leukemia clinical trials near me?
Yes, there are 100 acute myeloid leukemia clinical trials currently recruiting across 134+ cities in the United States, including Houston, Texas; Atlanta, Georgia; New York, New York. Browse the studies above to find one at a location convenient for you.
How do I join a acute myeloid leukemia clinical trial?
To join a acute myeloid leukemia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are acute myeloid leukemia clinical trials free?
Yes, participation in acute myeloid leukemia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of acute myeloid leukemia treatments are being studied?
Current acute myeloid leukemia clinical trials are testing a range of approaches across PHASE2 (51 studies), PHASE1 (45 studies), PHASE3 (12 studies), NA (4 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 61 research organizations.
Is it safe to participate in acute myeloid leukemia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 17, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 17, 2026 · Data from ClinicalTrials.gov